Koers Sigyn Therapeutics, Inc. Other OTC
Aandelen
SIGY
US82674U1060
Medische apparatuur, benodigdheden & distributie
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 6,08 mln. 5,65 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -2 mln. -1,86 mln. | Nettowinst (verlies) 2023 | -4 mln. -3,72 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,87 mln. 1,74 mln. | Nettoschuld 2023 | 2,47 mln. 2,29 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-2,13
x | K/w-verhouding 2023 |
-1,25
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 46,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Roberts
FOU | Founder | 71 | 19-10-19 |
James Joyce
CEO | Chief Executive Officer | 62 | 19-10-19 |
Jerry DeCiccio
DFI | Director of Finance/CFO | 67 | 12/12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Joyce
CEO | Chief Executive Officer | 62 | 19-10-19 |
James W. Dorst
BRD | Director/Board Member | 69 | 10-10-22 |
Richa Nand
BRD | Director/Board Member | 50 | 10-10-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,24% | 180 mld. | |
-6,08% | 99,21 mld. | |
-5,98% | 66,25 mld. | |
-9,35% | 44,74 mld. | |
+8,34% | 43,82 mld. | |
+10,35% | 41,96 mld. | |
+11,88% | 28,98 mld. | |
+16,18% | 24,07 mld. | |
-8,38% | 23,5 mld. |